
ARE Stock Forecast & Price Target
ARE Analyst Ratings
Bulls say
Alexandria Real Estate Equities Inc is positioned favorably due to its strategic expansion and presence in critical markets catering to life sciences, agtech, and technology tenants, which is expected to drive increased demand for purpose-built spaces. The company boasts a strong backlog of $10.8 billion, reflective of its robust construction segment growth and anticipated public sector demand, particularly in Canada. Additionally, anticipated improvements in biotech valuations and technology sector growth may further stimulate demand for lab space, enhancing the company's outlook amidst evolving market dynamics.
Bears say
The financial outlook for Alexandria Real Estate Equities Inc. remains negative due to several troubling indicators, including a year-over-year decline in operating results influenced by reduced management and development fees and the conclusion of significant contracts. The company faces significant challenges such as anticipated occupancy erosion, slowed leasing of new developments, and an oversupply of life science properties that is compounded by stagnant demand and reduced investment capital within the sector. Furthermore, the impact of government actions on research funding and the recent operating losses from legacy projects indicate a deterioration in the company's financial health, necessitating downward adjustments to earnings estimates and guidance for 2026.
This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares